Effect of weekly administration of bevacizumab, gemcitabine, and oxaliplatin in patients with heavily pretreated ovarian cancer

被引：0
|
作者：
Ikeda, Yuji
Kikuchi, Yoshihiro
Takano, Masashi
Goto, Tomoko
Kouta, Hiroko
Sasaki, Naoki
Kudoh, Kazuya
Oda, Katsutoshi
Nagasaka, Tsuneki
Kita, Tsunekazu
机构：
[1] Ohki Mem Canc Ctr Women, Tokorozawa, Saitama, Japan
[2] Natl Def Med Coll, Tokorozawa, Saitama 359, Japan
[3] Nishisaitama Chuo Natl Hosp, Tokorozawa, Saitama, Japan
[4] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan
[5] Kawakita Gen Hosp, Dept Obstet & Gynecol, Tokyo, Japan
[6] Nara Prefectural Nara Hosp, Nara, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5037
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effect of weekly administration of bevacizumab, eribulin, and oxalilplatin in patients with heavily pretreated serous ovarian carcinoma.
    Ikeda, Yuji
    Takano, Masashi
    Sasaki, Naoki
    Kita, Tsunekazu
    Kikuchi, Yoshihiro
    Kudoh, Kazuya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Weekly Administration of Bevacizumab, Gemcitabine, and Oxaliplatin in Patients With Recurrent and Refractory Ovarian Cancer A Preliminary Result of 19 Cases
    Ikeda, Yuji
    Takano, Masashi
    Oda, Katsutoshi
    Kouta, Hiroko
    Goto, Tomoko
    Kudoh, Kazuya
    Sasaki, Naoki
    Kita, Tsunekazu
    Kikuchi, Yoshihiro
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (02) : 355 - 360
  • [3] Chronic administration of single weekly paclitaxel in heavily pretreated ovarian cancer patients
    Yamamoto, K
    Oogi, S
    Inoue, H
    Kudoh, K
    Kita, T
    Kikuchi, Y
    [J]. CURRENT MEDICINAL CHEMISTRY, 2004, 11 (04) : 425 - 428
  • [4] Efficacy of gemcitabine in heavily pretreated advanced ovarian cancer patients
    Bilgin, T
    Özalp, S
    Yalçin, ÖT
    Zorlu, G
    Vardar, MA
    Özerkan, K
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (02) : 169 - 170
  • [5] Effects of weekly bevacizumab and pegylated liposomal doxorubicin in heavily pretreated patients with recurrent or progressed ovarian cancer
    Kikuchi, Y., Sr.
    Kouta, H.
    Kikuchi, R.
    Takano, M.
    Kita, T.
    Kudoh, K.
    Aoki, D.
    Sugiyama, T.
    Isonishi, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer
    Chura, Justin C.
    Van Iseghem, Kelin
    Downs, Levi S., Jr.
    Carson, Linda F.
    Judson, Patricia L.
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 326 - 330
  • [7] Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients
    Kossoff, Ellen B.
    Ngamphaiboon, Nuttapong
    Laudico, Thomas J.
    O'Connor, Tracey L.
    [J]. MEDICAL ONCOLOGY, 2011, 28 : S115 - S120
  • [8] Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients
    Ellen B. Kossoff
    Nuttapong Ngamphaiboon
    Thomas J. Laudico
    Tracey L. O’Connor
    [J]. Medical Oncology, 2011, 28 : 115 - 120
  • [9] THE EFFECT OF SINGLE WEEKLY PACLITAXEL IN HEAVILY PRETREATED OVARIAN CANCER PATIENTS AND ITS ANTIANGIOGENIC EFFECTS
    Kikuchi, Yoshihiro
    Kita, Tsunekazu
    Takano, Masashi
    Kudoh, Kazuya
    Saito, Keiko
    Fujii, Kazuyuki
    Sasaki, Naoki
    [J]. ANTICANCER RESEARCH, 2004, 24 (5D) : 3535 - 3535
  • [10] The effect of single weekly paclitaxel in heavily pretreated patients with recurrent or persistent advanced ovarian cancer
    Kita, T
    Kikuchi, Y
    Takano, M
    Suzuki, M
    Oowada, M
    Konno, R
    Yamamoto, K
    Inoue, H
    Seto, H
    Yamamoto, T
    Shimizu, K
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 92 (03) : 813 - 818
12345